Last news
Ailux Appoints Maria Belvisi, Ph.D., as Chief Scientific Officer

Ailux Appoints Maria Belvisi, Ph.D., as Chief Scientific Officer

Professor Belvisi joins from AstraZeneca, where she served as Senior Vice President, Research & Development, Respiratory & Immunology and built one of the most productive early R&D organizations in global pharma, including leading...

Narada Launches Next-Generation AIDC Backup Power System AIOn X-Rate

Narada Launches Next-Generation AIDC Backup Power System AIOn X-Rate

Breakthrough Technology Redefines Energy for the High-Compute Era HANGZHOU, China, April 10, 2026 /PRNewswire/ -- Amid the deep integration of artificial intelligence, cloud computing, and big data, global AIDC is entering a phase of explosive...

No More Seasonal Blues! iHerb Launches Spring "Defense-Focused" Health Guide: Discovering 6 Nutritional Essentials

No More Seasonal Blues! iHerb Launches Spring "Defense-Focused" Health Guide: Discovering 6 Nutritional Essentials

HONG KONG, April 10, 2026 /PRNewswire/ -- As spring arrives, drastic changes in temperature and environmental humidity often lead to "seasonal discomforts" such as fatigue and disrupted routines. Recognizing the rising demand for spring skincare and...

Countries pledge $3.9 billion to Global Environment Facility towards ambitious ninth replenishment

Countries pledge $3.9 billion to Global Environment Facility towards ambitious ninth replenishment

Four-year financing commitment supports accelerated action by developing countries towards 2030 environmental goals WASHINGTON, April 10, 2026 /PRNewswire/ -- Donor countries have pledged an initial $3.9 billion to the Global Environment Facility...

Lynk Pharmaceuticals Announces NDA Acceptance for Zemprocitinib by NMPA

Lynk Pharmaceuticals Announces NDA Acceptance for Zemprocitinib by NMPA

SHANGHAI, HANGZHOU, China and BOSTON, April 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today...

Hankook Strengthens Motorsport Presence at the 2026 Hi-Tec Oils Bathurst 6 Hour

Hankook Strengthens Motorsport Presence at the 2026 Hi-Tec Oils Bathurst 6 Hour

Hankook proves its top-tier technological leadership by serving as the official tyre supplier to the 'Bathurst 6 Hour' for the second consecutive year Ventus TD delivered consistent grip, stability and durability across six hours of racing...

Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies

Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies

SHANGHAI, April 10, 2026 /PRNewswire/ -- Oricell Therapeutics Holdings Limited ("Oricell"), a global clinical-stage biotechnology company pioneering innovative cancer immunotherapies, today announced the cumulative closing of a pre-IPO financing...

STRADVISION Files for KOSDAQ IPO, Targets Offering of 7 Million Shares

STRADVISION Files for KOSDAQ IPO, Targets Offering of 7 Million Shares

- Indicative Price Range Set at KRW 12,400–14,800 per Share SEOUL, South Korea, April 10, 2026 /PRNewswire/ -- STRADVISION, a global provider of AI-based vision perception software for the automotive industry, announced today that it has filed a...

1 ... 5 6 7 8 9 10 11 12 13 ... 4184
menu
menu